养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析  

Therapeutic Effect Analysisi of Yangxin Tablet Combined with Levothyroxine Sodium in Treatment of Hypothyroid Heart Disease

作　　者：潘伟[1] 陈聿峰[2] 韦彩芬 

机构地区：[1]广西科技大学第二附属医院核医学科,柳州545006 [2]广西科技大学第二附属医院心血管内科,柳州545006 [3]广西科技大学第二附属医院B超室,柳州545006

出　　处：《世界中医药》2016年第5期810-812,共3页World Chinese Medicine

基　　金：广西卫生厅自筹经费科研课题--左甲状腺素钠替代治疗甲状腺功能减退症对血管内皮功能影响的临床研究(编号:z2014019)

摘　　要：目的:观察养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析。方法:治疗组150例养心氏片联合左甲状腺素钠治疗;对照组100例单纯左甲状腺素钠治疗。结果:治疗组总有效率97.37%,明显优于对照组75.76%(P<0.05)。2组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM较本组治疗前均有改善(P<0.05);且治疗组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM均优于对照组治疗后(P<0.05)。结论:养心氏片联合优甲乐治疗甲状腺功能减退性心脏病疗效显著、改善症状快速,且无明显不良反应。Abstract Objective： To observe curative effect analysis Yangxin Tablet combined with levothyroxine sodium in treatment of hypo- thyroid heart disease. Methods：The treatment group included 150 cases, given the treatment of yangxin tablet combined with levo- thyroxine sodium, while patients in the control group with 100 cases were only given levothyroxine sodium treatment. Results ：The total effectiveness of the treatment group was 97.37% and was obviously better than that of the control group （75.76%） with sta- tistical significant difference （P 〈 0. 05 ）. T3, T4, FT3, FT4, TSH, LVEF, ATIII, FIB, and TM of both the two groups after treatment were improved, compared with those before treatment （ P 〈 0. 05 ） and those of the treatment group were superior to those of the control group （ P 〈 0. 05 ）. Conclusion： The curative effect of Yangxin Tablet combined with levothyroxine sodium in treat- ment of hypothyroid heart disease is distinct, with fast symptoms improvement and no obvious side effects.

关 键 词：养心氏片 左甲状腺素钠 甲状腺功能减退性心脏病 

分 类 号：R242[医药卫生—中医临床基础]